Giovanna de Melo Gasques
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Giovanna de Melo Gasques has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Ana Gabriella Costa Curado
Universidade de Rio Verde
1 shared publication - Beatriz Lima da Costa
Universidade Federal do Norte do Tocantins
1 shared publication - Daniel Machado Moura
Universidade de Rio Verde
1 shared publication - Gustavo Moura Bruder
Universidade de Rio Verde
1 shared publication - Hallamark Alvarez Lemos Portella
Faculdade de Medicina do Vale do Aço
1 shared publication - Igor Almeida Teixeira da Silva de Figueiredo
Medical Student Metropolitan University Center of the Amazon (UNIFAMAZ), Belém-Pará
1 shared publication
Latest Publications
- Open Access
- 14 May 2022
- Published by e-Academica in E-Acadêmica
- Vol. 3 (2) , e6232206
O agravamento das doenças reumáticas pós Covid 19: uma revisão integrativa
Introduction: COVID-19 is a disease caused by the new coronavirus, called SARS-CoV-2, an RNA virus, which initially emerged in Wuhan, China, in December 2019. asymptomatic and severe conditions, especially in patients with previous pathologies, such as patients with rheumatologic diseases. Method: The work was carried out in the form of an integrative review of the literature, it aimed to bring together the studies and identify the possible complications that rheumatic diseases would have in patients who contract COVID-19. Results/Discurssion: In view of the current health situation, the analysis of the studies showed that both COVID-19 and rheumatic diseases present a pathogenic cytokine, among the diseases rheumatoid arthritis, lupus erythematosus and primary Sjogren's spindrome. Conclusion: The work presented difficulties during its production, the greatest difficulty was the lack of literature that addresses the subject. Therefore, patients with DRIM must be evaluated individually and dimensioned for each clinical situation, especially in situations where COVID is suspected, in these cases the rheumatologist has a fundamental role in decision-making.
- 14 May 2022
- Published by e-Academica in E-Acadêmica
- Vol. 3 (2) , e6232206
Open AccessO agravamento das doenças reumáticas pós Covid 19: uma revisão integrativa
Introduction: COVID-19 is a disease caused by the new coronavirus, called SARS-CoV-2, an RNA virus, which initially emerged in Wuhan, China, in December 2019. asymptomatic and severe conditions, especially in patients with previous pathologies, such as patients with rheumatologic diseases. Method: The work was carried out in the form of an integrative review of the literature, it aimed to bring together the studies and identify the possible complications that rheumatic diseases would have in patients who contract COVID-19. Results/Discurssion: In view of the current health situation, the analysis of the studies showed that both COVID-19 and rheumatic diseases present a pathogenic cytokine, among the diseases rheumatoid arthritis, lupus erythematosus and primary Sjogren's spindrome. Conclusion: The work presented difficulties during its production, the greatest difficulty was the lack of literature that addresses the subject. Therefore, patients with DRIM must be evaluated individually and dimensioned for each clinical situation, especially in situations where COVID is suspected, in these cases the rheumatologist has a fundamental role in decision-making.